Anesthesia Knowledge Test-6 (AKT-6) Practice Exam 2026 - Free Anesthesia Practice Questions and Study Guide

The correct answer relates to the mechanism of action of the neuromuscular blockers listed. Of the options provided, pancuronium is a non-depolarizing neuromuscular blocker that does not inhibit plasma pseudocholinesterase. Instead, it's important to note that no non-depolarizing neuromuscular blockers actively inhibit plasma pseudocholinesterase; that is a characteristic of succinylcholine, a depolarizing neuromuscular blocker.

Pancuronium, vecuronium, and rocuronium are all non-depolarizing agents that work by competing with acetylcholine at the neuromuscular junction, thereby preventing muscle contraction. They are metabolized primarily by the liver and are not affected by plasma pseudocholinesterase.

Atacurium, another non-depolarizing neuromuscular blocker, is unique because it undergoes spontaneous degradation (Hofmann elimination and ester hydrolysis) independently of plasma pseudocholinesterase and may have some interaction with plasma cholinesterases, but it is not a specific inhibitor in the same context as succinylcholine.

The misconception might arise because one could think of neuromuscular blockers' interactions with metabolic pathways, but the distinguishing factor